Back to Market Feed

OLUMIANT 4 MG TABLET

baricitinib
$184.6620per EA

Strength

4 mg/1

NDC

00002447930

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

BARICITINIB

Approval Type

New Drug (NDA)

FDA Application

NDA207924

On Market Since

5/10/2022

Pharmacological Classes

Janus Kinase Inhibitor
Janus Kinase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.8%

3Y

N/A

5Y

N/A

All

+4.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

OPZELURA 1.5% CREAM
Brand
50881000705•Incyte Corporation
$34.1433
per GM
XELJANZ 5 MG TABLET
Brand
00069100101•Pfizer Inc.
$73.8329
per EA
XELJANZ 10 MG TABLET
Brand
00069100201•Pfizer Inc.
$103.5456
per EA
CIBINQO 100 MG TABLET
Brand
00069033530•Pfizer Inc.
$197.1952
per EA
XELJANZ XR 11 MG TABLET
Brand
00069050130•Pfizer Inc.
$207.7104
per EA
RINVOQ ER 30 MG TABLET
Brand
00074231030•AbbVie Inc.
$228.8254
per EA
RINVOQ ER 15 MG TABLET
Brand
00074230630•AbbVie Inc.
$229.2074
per EA
RINVOQ ER 45 MG TABLET
Brand
00074104328•AbbVie Inc.
$460.0432
per EA